Abstract
AIM: We investigate MAdCAM-1 as a reliable target to detect active bowel inflammation for selective noninvasive nanodiagnostics.
MATERIALS & METHODS: We coupled anti-MAdCAM-1 antibodies to manganese oxide nanoparticles, and analyzed nanoconjugate biodistribution and safety in murine model of inflammatory bowel disease by imaging and histology.
RESULTS: Nanoparticles were stable and nontoxic. Upon administration in colitic mice, anti-MAdCAM-1 functionalized nanoparticles preferentially localized in the inflamed bowel, whereas untargeted nanoparticles were more rapidly washed out. Nanoparticles did not induce lesions in nontarget organs.
CONCLUSION: Anti-MAdCAM-1 functionalized nanoparticles detected active bowel inflammation foci, accurately following MAdCAM-1 expression pattern. These nanoconjugates could be a promising noninvasive imaging system for an early and accurate follow-up in patients affected by acute colitis.
Original language | English |
---|---|
Pages (from-to) | 1547-1560 |
Number of pages | 14 |
Journal | Nanomedicine |
Volume | 12 |
Issue number | 13 |
DOIs | |
Publication status | Published - Jul 2017 |
Keywords
- Animals
- Antibodies
- Cell Survival
- Colitis
- Hemolysis
- Humans
- Immunoglobulins
- Male
- Manganese Compounds
- Metal Nanoparticles
- Mice
- Mice, Inbred C57BL
- Mucoproteins
- Oxides
- Particle Size
- Surface Properties
- Tissue Distribution
- Journal Article